Zullo Investment Group, Inc. Pfizer Inc Transaction History

Zullo Investment Group, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 24, 2024	SELL	$25.89 - $29.73 $152,932 - $175,615	-5,907 Reduced 38.23%	9,545 $264,000
Q4 2023 Jan 19, 2024	SELL	$26.13 - $33.94 $53,697 - $69,746	-2,055 Reduced 11.74%	15,452 $444,000
Q3 2023 Oct 19, 2023	BUY	$32.09 - $37.51 $930 - $1,087	29 Added 0.17%	17,507 $580,000
Q2 2023 Jul 19, 2023	SELL	$36.12 - $41.79 $14,736 - $17,050	-408 Reduced 2.28%	17,478 $641,000
Q1 2023 Apr 25, 2023	BUY	$39.39 - $51.28 $10,832 - $14,102	275 Added 1.56%	17,886 $729,000
Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $1,878 - $2,452	45 Added 0.26%	17,611 $902,000
Q3 2022 Nov 08, 2022	BUY	$43.76 - $53.42 $24,286 - $29,648	555 Added 3.26%	17,566 $769,000
Q2 2022 Aug 11, 2022	SELL	$46.53 - $55.17 $10,283 - $12,192	-221 Reduced 1.28%	17,011 $892,000
Q1 2022 May 16, 2022	BUY	$45.75 - $56.69 $26,489 - $32,823	579 Added 3.48%	17,232 $892,000
Q4 2021 Feb 16, 2022	BUY	$41.32 - $61.25 $688,101 - $1.02 Million	16,653 New	16,653 $983,000

3,260

3.73B

73.5M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Zullo Investment Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Zullo Investment Group, Inc. with notifications on news.